CHELSEY HUFF: Open Payments
NPI 1548807647 · MT JULIET, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 113 payments from 16 companies in 2025. Trend: 2023 $2,531 · 2024 $2,090 · 2025 $2,096
Food & beverage: $2,096
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $396 |
| AstraZeneca Pharmaceuticals LP | 13 | $315 |
| Lilly USA, LLC | 16 | $306 |
| ABBVIE INC. | 20 | $212 |
| GlaxoSmithKline, LLC. | 10 | $180 |
| Corcept Therapeutics | 6 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| PFIZER INC. | 4 | $82 |
| Astellas Pharma US Inc | 3 | $70 |
Products named: Ozempic, BREZTRI, MOUNJARO, Korlym, ZEPBOUND, TRELEGY ELLIPTA, CAPLYTA, Wegovy.
Industry payments across TN — which companies pay providers there.
